|
E2F6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.622000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.549600E-01 |
| Normal-vs-Stage2 |
9.221800E-02 |
| Normal-vs-Stage3 |
4.577800E-03 |
| Normal-vs-Stage4 |
2.321800E-03 |
| Stage1-vs-Stage2 |
3.225600E-01 |
| Stage1-vs-Stage3 |
2.690400E-02 |
| Stage1-vs-Stage4 |
2.036400E-02 |
| Stage2-vs-Stage3 |
5.752200E-01 |
| Stage2-vs-Stage4 |
3.259200E-01 |
| Stage3-vs-Stage4 |
5.037400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.969900E-02 |
| Normal-vs-AfricanAmerican |
8.558400E-01 |
| Normal-vs-Asian |
6.682600E-01 |
| Caucasian-vs-AfricanAmerican |
2.214400E-01 |
| Caucasian-vs-Asian |
1.417980E-01 |
| AfricanAmerican-vs-Asian |
8.950600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.103560E-02 |
| Normal-vs-Female |
6.647900E-02 |
| Male-vs-Female |
1.881600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.789400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.778230E-02 |
| Normal-vs-Age(61-80Yrs) |
9.218700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.019400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.068400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.501530E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.313800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.064800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.707000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.752600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.69510999999956E-05 |
| Classical-VS-Follicular |
7.434400E-02 |
| Classical-VS-Other |
3.148200E-01 |
| Classical-VS-Normal |
3.064400E-01 |
| Tall-VS-Follicular |
1.515980E-02 |
| Tall-VS-Other |
3.322200E-01 |
| Tall-VS-Normal |
3.75980000000276E-05 |
| Follicular-VS-Other |
7.386200E-01 |
| Follicular-VS-Normal |
3.200300E-02 |
| Other-VS-Normal |
1.325550E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.890000E-02 |
| Normal-vs-N1 |
3.247900E-02 |
| N0-vs-N1 |
6.155800E-01 |
|
|
